

Current Location：HOME>NEWS

6
11月
Qidu Biopharma Successfully Obtains ISO Management System Certifications
On October 11, Qidu Biopharma officially received the ISO9001 Quality Management System and ISO13485 Medical Devices Quality Management System certification certificates. The company established and i
6
11月
Qidu Pharma's Qisai®-Pioglitazone and Metformin Tablets was Approved for Marketing
Qidu Pharma's Qisai®-Pioglitazone and Metformin Tablets, a drug for the treatment of type 2 diabetes, has been officially approved by the National Medical Products Administration (NMPA). The drug appr
6
11月
Qidu Pharma Achieves Outstanding Results at the National Pharmaceutical Industry QC Group Achievements Exchange Conference
The National Pharmaceutical Industry QC Group Achievements Exchange Conference was first held in 1979 by the China Quality Association for Pharmaceuticals (CQAP) and has been held annually since, esta
14
10月
Qidu Pharma was Selected as "National Exemplary Smart Factory"
On September 12, the Ministry of Industry and Information Technology completed the public announcement of the "2025 Exemplary Smart Factory Project List." Qidu Pharma's application for its "Fully Digi
14
10月
Two Key Products of Qidu Pharma were approved for marketing
On July 29, 2025, Qidu Pharma received market approval for Qiliwei® (Peramivir Sodium Chloride Injection), the first generic version in China. This product is certified as bioequivalent to the referen

1
2
3
4
5
6
7
8
9
10
11
Next